Virus injection takes on Hard-to-Treat cancers in early trial
NCT ID NCT05914376
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 23 times
Summary
This early-phase study tests a new treatment called hV01, a modified virus designed to infect and kill cancer cells while boosting the immune system. It is for people with advanced solid tumors that have not responded to standard therapies. The main goal is to check the safety of injecting the virus directly into tumors and to find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China
-
Zhejiang People's Hospital
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.